14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:GNCA
Delisted

Genocea Biosciences Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Apr 19, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 18, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 17, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 14, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 13, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 12, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 11, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 10, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 06, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 05, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 04, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Apr 03, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 31, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 30, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 29, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 28, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 27, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 24, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 23, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 22, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 21, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 20, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 17, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 16, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Mar 15, 2023 $0.0001 $0.0001 $0.0001 $0.0001 0
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT